![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least seven days
|
|
|
Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
IAS: MK-8591 Protects 8 of 8 Macaques From Rectal SHIV 6 Days After Dosing - (07/23/17)
Randolph P. Matthews1, Dirk Schurmann2, Deanne Jackson Rudd1, Vanessa Levine1, Sabrina Fox-Bosetti1, Sandra Zhang1, Martine Robberechts1, Inge De Lepeleire1, Andreas Huser2, Daria J. Hazuda1, Marian Iwamoto1, and Jay A. Grobler1 on behalf of the HIV Early Development Team. 1MSD, Kenilworth, NJ, USA; 2Charité Research Organisation, Berlin, Germany.
![IAS1](../images/072517/072517-6/IAS1.gif)
![IAS2](../images/072517/072517-6/IAS2.gif)
![IAS3](../images/072517/072517-6/IAS3.gif)
![IAS4](../images/072517/072517-6/IAS4.gif)
![IAS5](../images/072517/072517-6/IAS5.gif)
![IAS6](../images/072517/072517-6/IAS6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|